Pathophysiology-Based Management of Secondary Injuries and Insults in TBI
Authors:
- Leonardo de Macedo FilhoLFLeonardo de Macedo Filho
- Luisa F. FigueredoLFLuisa F. Figueredo
- Gustavo Adolfo Villegas-GomezGVGustavo Adolfo Villegas-Gomez
- Matthew ArthurMAMatthew Arthur
- Maria Camila Pedraza-CiroMPMaria Camila Pedraza-Ciro
- Henrique MartinsHMHenrique Martins
- Joaquim Kanawati NetoJNJoaquim Kanawati Neto
- Gregory J. HawrylukGHGregory J. Hawryluk
- Robson Luís Oliveira AmorimRARobson Luís Oliveira Amorim
Top Cited Papers
Open Access
- 26 February 2024
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 12 (3) , 520
Abstract
Traumatic Brain Injury (TBI) remains a leading cause of morbidity and mortality among all ages; despite the advances, understanding pathophysiological responses after TBI is still complex, involving multiple mechanisms. Previous reviews have focused on potential targets; however, the research on potential targets has continuously grown in the last five years, bringing even more alternatives and elucidating previous mechanisms. Knowing the key and updated pathophysiology concepts is vital for adequate management and better outcomes. This article reviews the underlying molecular mechanisms, the latest updates, and future directions for pathophysiology-based TBI management.Keywords
This publication has 134 references indexed in Scilit:
- Hemorrhagic Progression of a Contusion after Traumatic Brain Injury: A ReviewJournal of Neurotrauma, 2012
- Expression of the 2′,3′‐cAMP‐adenosine pathway in astrocytes and microgliaJournal of Neurochemistry, 2011
- Clinical Relevance of Cortical Spreading Depression in Neurological Disorders: Migraine, Malignant Stroke, Subarachnoid and Intracranial Hemorrhage, and Traumatic Brain InjuryJournal of Cerebral Blood Flow & Metabolism, 2010
- The Cytokine Response to Human Traumatic Brain Injury: Temporal Profiles and Evidence for Cerebral Parenchymal ProductionJournal of Cerebral Blood Flow & Metabolism, 2010
- Calpain as a Therapeutic Target in Traumatic Brain InjuryNeurotherapeutics, 2010
- Key Role of Sulfonylurea Receptor 1 in Progressive Secondary Hemorrhage after Brain ContusionJournal of Neurotrauma, 2009
- Drug targets for traumatic brain injury from poly(ADP‐ribose)polymerase pathway modulationBritish Journal of Pharmacology, 2009
- Post‐injury baicalein improves histological and functional outcomes and reduces inflammatory cytokines after experimental traumatic brain injuryBritish Journal of Pharmacology, 2008
- Moderate and severe traumatic brain injury in adultsThe Lancet Neurology, 2008
- Necrostatin-1 Reduces Histopathology and Improves Functional Outcome after Controlled Cortical Impact in MiceJournal of Cerebral Blood Flow & Metabolism, 2008